Incyte (INCY) cash: $3.1B
Incyte held $3.1B in cash and cash equivalents on Dec 31, 2025, up 83.5% from $1.7B a year earlier.
From Incyte's filings with the SEC · Read the filing · INCY stock page
Incyte cash by year
#199 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $3.1B | +84% |
| Dec 31, 2024 | $1.7B | -47% |
| Dec 31, 2023 | $3.2B | +9% |
| Dec 31, 2022 | $3B | +43% |
| Dec 31, 2021 | $2.1B | – |
Cash of similar companies
Companies in the same industry as Incyte, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Incyte | $3.1B | Dec 31, 2025 |
| Iqvia | $2B | Dec 31, 2025 |
| Icon | $647M | Dec 31, 2025 |
| Medpace Holdings | $497M | Dec 31, 2025 |
| Charles River Laboratories International | $214M | Dec 27, 2025 |
| OmniAb | $25.5M | Dec 31, 2025 |
| Absci | $20M | Dec 31, 2025 |
Questions and answers
What is Incyte's cash?
Incyte held $3.1B in cash and cash equivalents on Dec 31, 2025, up 83.5% from $1.7B a year earlier.
Numbers as reported in Incyte's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology